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AIM OF STUDY: 
To describe how doctors are prescribing low dose antidepressants at Heideveld 
Community Health Centre. 
OBJECTIVES: 
1. To detemrine how many patients are being prescribed low dose antidepressants at 
Heideveld Community Health Centre. 
2. To see what sort of dosages are being prescribed as low dose most frequently. 
3. To see if indications for the use of low dose tricyclic antidepressants are being 
recorded. 
4. To identify the indications for the use of low dose tricyclic antidepressant. 
IV 
METHOD: 
A total of 500 patient folders were reviewed. 50 patient folders, (10 folders each from 
five medical officers), were systematically sampled, per day, for ten days over a two 
week period. Records were reviewed and data was captured on a data capture sheet. 
Demographic data: age and gender was recorded. The dose of the antidepressant per 
patient was recorded. The indication for its use was recorded. Where the indication of its 
use was not recorded, this was also documented. 
RESULTS: 
1. Of the 500 folders reviewed, a total of 153 (30,6%) of the patients were 
prescribed low dose tricyclic antidepressants at the consultation, during the 
time that the study took place. 
2. The minimum dose used was IOmg and the maximum dose used was 75mg of 
tricyclic antidepressant. The median dose used was 25mg. 
3. 83% of the folders had reasons for the use oflow dose tricyclic antidepressant 
recorded. 17% of the folders had no reason recorded. 
v 
4. The reasons for using low dose tricyclic antidepressants, were for chronic pain 
syndromes, insomnia, somatic symptoms and for psychological or psychiatric 
reasons (anxiety or depression related symptoms). 
CONCLUSION 
Low dose tricyclic antidepressants were justifiably prescribed for the many non-
psychiatric and psychiatric conditions that respond to it, at Heideveld Community Health 
Centre. 
VI 
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I am at present a medical officer at the Heideveld Community Health Centre. I have been 
working at this centre, for the past nine years, and have found primary health care to be 
extremely rewarding. 
The Heideveld Community Health Centre, serves the people of Heide veld, Surrey Estate, 
Welcome Estate, Vanguard Estate, Manenberg, Bonteheuwel, Guguletu and Langa. The 
patients served at our clinic come mainly from poor socio-economic backgrounds. The 
social, cultural, political, and economic problems experienced, are enormous, and these 
impact heavily on their physical and mental health, as well. 
We provide a comprehensive service to our patients, with a multidisciplinary team on our 
staff. The staff at the clinic includes five medical officers, nursing staff, a part-time surgeon, 
a social worker, a radiographer, a physiotherapist, a dentist, two pharmacists, three 
pharmacy assistants, and two psychiatrically trained nurses. 
Our health centre is known for its good quality care and services provided, in the 
community. 
Due to the large number of patients, and on-going shortage of staff, it has become 
almost routine for non-pharmacy staff members to assist at the pharmacy, where there is 
often a huge waiting queue of patients at the end of the day. It was after helping out at the 
pharmacy that our physiotherapist commented that she wondered why almost all of the 
patients attending our clinic were on Amitriptyline, a tricyclic antidepressant, and they were 
not psychiatric patients. (Our patients attending the psychiatric clinic, had separate blue 
folders, compared to our usual yellow folders, or the more recent folders of patients attending 
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the psychiatric clinic, then had a bold letter "P" on the side of the folder). Thus she knew the 
difference between the folders. She commented that she thought, we were prescribing it as a 
means to "solve all the people's problems rather than counselling them for their depression, 
because of the limited time available for consultations. It 
(Amitriptyline and Imipramine were the only two tricyclic antidepressant drugs available, 
to be prescribed by us, medical officers, on the open pharmaceutical code. The other 
antidepressants were available on restricted codes, to psychiatrists only). 
Were there really so many patients on antidepressants, and why were they on these drugs? 
Knowing that doctors (myself included), generally referred psychiatric patients to the 
psychiatric sister, (seeing that she was always available to consult, as well as having a 
visiting psychiatric consultant on a weekly basis), it seemed obvious that not all the patients 
would have come for psychiatric reasons. The alleged abundant usage of the antidepressants 
was therefore, most probably for non-psychiatric reasons. I thus decided that this would be an 
interesting and useful study, for me and for the health centre, to undertake, looking at the 
prescribing habits of doctors at the Heideveld Community Health Centre, when prescribing 
antidepressants. 
2 
2. LITERATURE REVIEW 
I searched the literature using Medline, limited to English publications, from January 1980-
December 2003, and also used relevant reference books. 
The tricyclic antidepressants are a group of drugs that have been found to have 
antidepressant properties. 
The tricyclic antidepressants, have a characteristic three ring nucleus, and their actions 
closely resemble the phenothiazines chemically and to a lesser extent their 
pharmacological actions as well.} They were initially useful as antihistamines, and then 
later used as antipsychotics.] They are now commonly used for depression, anxiety and 
numerous other non-psychiatric conditions. Amitriptyline and Imipramine are the prototypes 
of the class of tricyclic antidepressants. } 
Absorption, distribution, metabolism, and excretion of tricyclic antidepressants are very 
variable in different individuals. Their onset of action is slow and usually ranges from 2-3 
hours. Between 3 and 8 hours, a peak plasma concentration is achieved. Plasma half life 
ranges from 10-20 hours for a dose. The drug is metabolised by the liver and excreted by the 
kidneys.] 
Tricyclic antidepressants have immediate anticholinergic and sedative effects, but the 
antidepressant effect takes about 6 weeks. Sleep or pain modification response also varies 
among individuals. The tricyclics act primarily on the central nervous system by inhibiting 
the uptake of biogenic neurotransmitter amines. They have variable sedative and 
anticholinergic actions. ],52 
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Recent articles suggest the potential benefits of tricyclic antidepressants in a number of non-
psychiatric conditions. 
Leo Hollisterl in his introduction to the chapter on antidepressants, states that depression can 
be readily diagnosed, if it is the main complaint In practice, this is rarely the case. He states 
that a host of other complaints mask the true depression, and the general feeling is that 
anybody with vague, complaints, that cannot be medically explained, is suspected of being 
depressed. 
The symptoms of both depression and anxiety often occur together. Some of the symptoms 
described by anxious or depressed patients include headache, tiredness, insomnia, chronic 
pain, musculoskeletal aches and pains, strange tastes, or strange cutaneous sensations. 
Moore2 in his article, states that 30-40010 of patients attending general practitioners, who are 
depressed, are not being diagnosed, as depressed. Many patients, especially those with 
physical complaints, or less severe depression are thus missed. He also states that doses of 
antidepressants, being prescribed for patients who are diagnosed as being depressed, are 
"below the therapeutic threshold." 
Psychiatrists often start off with low dose tricyclics, and within one to two weeks, push 
patients up to full dose for therapeutic effects in the treatment of clinical depression. 
Richeime? describes low dose tricyclics as being <5Omg, and he describes full dose 
tricyclics as anything> 15Omg. 
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Broadhead 4 in his study, after reviewing numerous articles, states that tricyclics may have 
"specific beneficial effects" on all of the common physical symptoms of depression, in 
depressed patients. It is now well documented that tricyclics are used successfully in other 
psychiatric illnesses, such as panic disorders, obsessive compulsive behaviours, agoraphobias 
attention deficit disorders8 and bulimia8 as well as non psychiatric disorders, such as peptic 
ulcer disease8. irritable bowel syndrome 11 tension headaches, prophylaxis of migraine,9, 10 
functional chest pain, 11,12 smoking cessation programmes, urinary incontinence,13 enuresis13 
chronic pelvic pain14 neuropathic cancer painlS chronic muscle pains,16 chronic lower back 
pain17 insomnia, 23 chronic pain syndromes, neuropathies,17,18,19,20 tinnitus,26,27 cutaneous 
dysesthesia syndrome19 and fibromyalgia syndrome6• 
Broadheado4 also states in his article, that doctors often do not document psychiatric 
diagnoses, when prescribing psychotropic medication. Reasons for this poor documentation 
were thought to be due to "inadequate evaluation of the patients by the physicians, a lack of 
proper physician training and a lack of vocabulary for describing recognised psychological 
distress in patients, poor record keeping, or physicians' reluctance to record a mental disorder 
as the diagnosis." He also suggested that the patients treated, did not necessarily have a 
psychiatric disorder but may have had illnesses responding to tricyclics. 
Broadhead 4 also stated that during visits to a primary care physician within one year, 65% of 
patients were prescribed tricyclic antidepressants, both for psychiatric and non psychiatric 
reasons. He also suggested that "current estimates that only 55% of tricyclic prescriptions are 
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based on an appropriate diagnosis are probably too low, and may reflect the omission of the 
tricyclic antidepressant-responsive diagnoses." 
OrnsteinS also highlighted the high prevalence and wide inter-practice variations of 
depression diagnosis and the use of antidepressants in primary health care. They also stated 
that more than 40010 of patients in their study had received antidepressants, but had not 
received a diagnosis of depression. 
Jencks7S stated that mental symptoms are recognised and managed in many cases where a 
mental diagnosis is NOT made. He also stated that "psychotropic drugs are often prescribed, 
WITHOUT a recorded diagnosis of mental disorders." He also makes mention of the fact that 
subjects who received treatment without a diagnosis tended to be patients with established 
other diagnoses, who had a shorter consultation time and were more likely to have a follow-
up appointment. 
He states that one needs to consider that doctors could be deliberately under- diagnosing 
patients with depressive disorders, to "reduce stigma" or for "future insurance eligibility" 
purposes, or due to the "poor specificity of the diagnostic categories (e.g. depression not 
otherwise specified versus adjustment disorder with depressed mood.)" 
"General practitioners frequently do not detect depressive states, tend to under- treat 
depression and fail to take up evidence-based guidelines in the area of depression," according 
to Anderson 74. In his study, Anderson found that doctors considered antidepressants 
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important and had increased prescribing of antidepressants, but some of them were sceptical 
about the increase in prescribing antidepressants and they were uncertain about the correct 
criteria for diagnosing and treatment of depression. He also found that general practitioners 
lacked the ability to recognise depression in the depressed patients in their own practices. 
A study, according to Olfson73 revealed that the greatest increase in prescribing 
antidepressants, in their study, was for patients with adjustment disorders and less severe 
psychiatric disorders. A depressive disorder was diagnosed in 59010 of patient visits in the 
1993-1994 National Ambulatory survey amongst medical care of children and adolescents. 
The study did not provide information about dosages, or duration of the antidepressant used 
or the specific condition for which the medication was prescribed. The authors stated that 
they were "uncertain about the reliability of the diagnosis established by the prescribing 
doctor". 
Somatisation is the most common presentation of psychiatric disorder in both general and 
hospital practices, and for most patients, it is the presenting feature of anxiety and mood 
disorders.34 
According to Kroenke71 10-15% ofprimary care patients present with somatofonn disorders. 
He stated that studies showed that somatofonn disorders produce significant impairment in 
patients' functioning and quality of life which could compare to mood and anxiety disorders. 
Somatofonn disorders are also associated with increased health care costs and services, since 
patients present frequently, more diagnostic tests get done on them, they get prescribed more 
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medication on their frequent visits and may be referred more often to specialists and be 
subjected to more surgical and diagnostic procedures. Patients with these disorders may be 
more difficult and challenging to care for and may be a source of frustration for both the 
patient and the doctor treating the condition. 
Epstein48 stated that a symptom such as chronic fatigue can be a symptom associated with 
almost any medical disorder or almost any psychiatric disorder as well. From his reviews, 
more than two thirds of chronically fatigued patients have coexistent psychiatric illnesses. 
Approximately half of the patients had depression and the remainder had anxiety or 
somatofonn disorders. 
Sheehan 65 found somatisation to be common among older primary care attendees and was 
associated with depression and chronic physical disorders. Rates of depression in these 
patients were also higher in the older patients with lower social support. He also stated that 
older people with psychological distress were more likely to present with somatic symptoms, 
in a system that was likely to "under-detect and under-treat psychiatric disorders. tI It was 
shown that depression in the elderly is often unrecognised. Somatisation was suggested as a 
reason for under-detection. Medical illnesses causing somatisation and depression, is more 
common in older people, therefore a clear understanding of the prevalence and association of 
somatisation among older people is needed. 
Kroenke and Spitzer67 in their study showed that females were more likely to have somatic 
symptoms. They suggested that the greater reporting of most symptoms, including 
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unexplained symptoms, by females, may account for the increased prevalence of functional 
syndromes among women, including irritable bowel syndrome, fibromyalgia, chronic fatigue 
syndrome, and migraine headaches. Depression and anxiety disorders were both strongly 
associated with symptom reporting in their study. They found that depression had a greater 
effect on total symptom reporting, while patients with anxiety reported more somatoform 
symptoms. They state that nwnerous theories have been proposed to account for the 
increased symptom reporting in females. On a physiological level, females are more sensitive 
to external environmental stimuli including stress and men to internal physiological stimuli in 
noticing, defining and reacting to physical symptoms. Certain psychological factors more 
prevalent in females are strongly associated with increased symptom reporting especially 
depressive and anxiety disorders, as well as a histoty of physical or sexual abuse. Greater 
expressiveness and less stoicism among females, amplification of somatic symptoms and a 
lower threshold for seeking health care and gender differences in social roles and 
responsibilities, are some of the cultural factors postulated for the increased symptom 
reporting. 
Kroenke and Spitzer67 also stated that interviewing a patient to establish the presence or 
absence of a somatoform disorder can be time intensive, because the clinician must gather 
sufficient information from the patient and medical records to ascertain that a physical 
explanation for somatic complaints is unlikely. 
Recognising that depressed patients often present to their doctors with physical symptoms 
that may mimic other diseases, such as chronic pain, fatigue, gastrointestinal symptoms, 
9 
rather than presenting with the usual symptoms of sadness, hopelessness or loss of pleasure 
in usual activities, is important, in order to treat appropriately and to improve the quality of 
life and to reduce their excessive use of health care facilities according to De-Wester.35 
Anxiety is commonly found in adults with depressive disorders, either alone or as a co-
morbid disorder. Lenze46, in his study stated that an estimated 85% of adults with depression 
experience significant symptoms of anxiety. He also stated that depressed elderly patients 
were more likely to seek treatment than younger patients, either due to "greater physical 
illness or greater psychological distress, both of which are associated with geriatric 
depression and anxiety disorders". He also stated that the elderly patients were more likely to 
have poorer social functioning and increased somatic symptoms associated with anxiety 
disorders. High levels of somatic symptoms during treatment, may be interpreted by either 
the patient or the doctor to be a side-effect of the medication, and could lead to compliance 
problems or stopping medication too early. His findings also suggested that symptoms of 
generalised anxiety disorder in patients with co- morbid depression, predict greater severity 
in depressed elderly patients. 
Patients, who present with unexplained physical symptoms, are associated with both higher 
levels of psychiatric symptoms and abnormal attachment behaviours when compared to 
patients presenting with organic physical symptoms. Their "medical help seeking behaviour" 
is a form of "care eliciting behaviour," and as such may be understandable in terms of 
"attachment style" and may affect relationships with their professional carers, according to 
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Taylor49, in his article about attachment types in patients with unexplained physical 
complaints. This could also account for the increased utilisation of hea1th- care resources. 
Ballingef30 reports that "sociocultural and family factors are more important in the aetiology 
of symptoms of menopausal women, than physiological changes." He reports that anxiety 
and depression in some women do not respond to oestrogen therapy, but do respond to 
antidepressants used by them. 
In psychosomatic illness, psychological factors may well aggravate, prolong or cause 
relapses in an illness, whose basis is physical. McDaniel72 states that despite very difficult 
life situations, somatically fixated patients tend to present with nwnerous physical symptoms, 
and not with anxiety, depression, or trouble with coping. In one of their studies reviewed, 
more than half of their patients at a practice presented with unexplained medical symptoms. 
In another study72 they found that these patients had a 5% higher rate of attending and 5% 
higher charges and had folders that were almost twice as thick as the average folder. 
Psychogenic symptoms are often based on a vicious cycle, e.g. emotional distress causing 
muscular tension, which causes pain, which in turn worsens anxiety or emotional stress (e.g. 
fearing pain may be cancer- related), which in turn causes more muscular tension, which 
again increases pain, etc. thus repeating the cycle and causing increased visits to the health 
care centres. 
Nwnerous studies have been done to confirm the efficacy of tricyclics in the treatment of 
non- psychiatric disorders. Many of these are not "purely non-psychiatric" and may often be 
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accompanied by an axis 1 diagnosis such as "psychological factors affecting physical 
condition" in DSM III-R classification. Cunha36 states that antidepressants are recommended 
by some clinicians to treat irritable colon, even when there is no evidence of depression, 
since this illness may represent a type of "masked depression" in the elderly. 
Many patients with chronic pain syndromes have been treated successfully with 
antidepressants, whether or not if they had depression. In most of the cases, chronic pain is 
accompanied by mild depression.6 It is not clear if painful states represent depressive states 
or if patients become secondarily depressed, because of the chronic pain states. 
It was found that low dose tricyclics helped in relieving pain in patients with rheumatoid 
arthritis either with or without ~ but it did not have a significant effect on depression, in 
patients who had it. 6 
Richeime~ stated that antidepressants are analgesic, if they relieved depression which gave 
rise to ~ but some were shown to be analgesic in the absence of depression. 
Chronic pain is a common presentation in the primary health care setting. It is often very 
frustrating to both patient and doctor alike. Among the conditions under the chronic pain 
syndromes are chronic lower back ~ fibromyalgia, chronic tension headaches, 
neuropathy, chronic pelvic pain, post herpetic neuralgia and cancer pain. The treatment of 
patients with chronic pain syndromes requires a multidisciplinary approach. 3 
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Antidepressants are considered to be the first choice of treatment for patients with diabetic 
peripheral neuropathy, in numerous studies reviewing and evaluating the drug therapy of 
patients with diabetic peripheral neuropathy, according to Wright.21 
Chronic phantom limb pain is a sequel of amputations. Interactions between 
pathophysiological mechanisms in the peripheral and central nervous systems may be 
responsible for the initiation and maintenance of chronic phantom limb pain as reported in 
Wright's article.21 
Tricyclic antidepressants provided partial symptomatic relief for patients with predominantly 
sensory neuropathy in patients with AIDS and AIDS related complex, according to Comblath 
et al.20 The most common type of peripheral neuropathy associated with Human 
Immunodeficiency Virus infection, affecting 10-300/0 of patients with mv, according to him, 
is predominantly sensory neuropathy. 
Orsulakl states that lower doses of antidepressants were effective in patients with chronic 
pain. He also reported that tricyclic antidepressants are far superior to placebo in migraine 
prophylaxis. Preventative treatment is often given daily for months or years. Interestingly 
enough, Silberstein9 reports that most migraine preventative medications were designed to 
treat other disorders. (e.g. propanolol for hypertension, valproate for epilepsy), before it was 
used for preventative treatment. 
The National Heart, Lung and Blood Institute working group on insomnia42 revealed that 
from 30 to 40 percent of adults indicate some level of insomnia within any giVet1 year and 
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about 10 to 15 percent indicate that the insomnia is chronic, severe or both. They reported 
that the prevalence of insomnia increased with age and was more common in women. They 
reported that patients with chronic insomnia frequently complained about "fatigue, mood 
swings, irritability, depression and impaired daytime functioning." They reported that 
insomnia appeared to "contribute to increased rates of absenteeism, health care utilisation, 
and social disability." 
Simon et al41 states that "epidemiological surveys have shown that sleep disturbance is more 
prevalent among the elderly, those with chronic medical illness and those with anxiety or 
depressive disorders." They also stated that prevalence rates of self reported sleep difficulty 
range from 1 0-40% and this, in itself, leads to poor general health, increased absenteeism, 
and an increased use of medical services. They also found that the patients with insomnia had 
more illnesses and a higher prevalence of depression, functional impairment and increased 
health care visits which might reflect the confounding influence of chronic medical illness 
and/or depression.41 
In addition, they also reported that both insomnia and depression made independent 
contributions to disability and health care utilisation, but that it could also be part of a vicious 
cycle, in which insomnia can lead to a depressed mood and loss of interest, which often leads 
to functional impairment and likewise, insomnia can also be a mediator between depression 
and disability. 
Similarly, Walsh4o, in their study reported that insomnia is associated with "higher than 
normal levels of anxiety, depression, medical illness and social disability."Walsh40 concluded 
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that there had been a "dramatic shift to the use of antidepressants, in lieu of hypnotics, for the 
symptomatic treatment of insomnia," despite a paucity of data regarding their efficacy and 
the potential for serious side effects. He also reported that insomnia is also a risk factor for 
the onset of depression, if it persists for one year. 
All of the alx)Ve psychiatric and non psychiatric conditions are common conditions seen on a 
daily basis at our day hospital, and the literature provides enough evidence for the use of 
antidepressants in our patients presenting with these conditions. 
2.1 BACKGROUND MEDICAL INFORMATION ABOUT MAIN FACTORS IN STUDY 
2.1.1 ANXIETY DISORDERS 
Anxiety is a SUbjective feeling of fear and apprehension, accompanied by an overwhelming 
feeling of impending doom.34 The symptoms and signs associated with anxiety include many 
features consisting of affective, cognitive, behavioural and somatic symptoms. The patients 
often feel a sense of dread or panic causing them to seek to neutralize the distress and to 
reflect their anxious states by certain responses to it (e.g. avoidance behaviours). They may 
appear restless, agitated, jittery, with heightened arousal including being hyper-vigilant, 
distractible, with impaired concentration, and insomnia. 34 The somatic manifestations may 
mimic many medical conditions in which there is stimulation of the sympathetic nervous 
system, causing autonomic hyper reactivity and include systemic (fatigue, weakness, 
insomnia), cardiopulmonary (palpitations, chest pain, dyspnoea, hyperventilation), 
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gastrointestinal (nausea, vomiting, diarrhoea, dry mouth), urinary (frequency) and neurologic 
(dizziness, tremulousness, restlessness, near syncope, paraesthesia) symptoms.34 
2.1.2 DEPRESSION 
Clinical depression can be distinguished from transient depressive moods and depressive 
personality by three main features, the depressive illness being a sustained depression of 
mood, lasting for weeks or months. The depression is severe enough to interfere with normal 
daily life and it has a definite onset with a clear, noticeable change from normal to depressive 
thinking. 33 
A patient who presents with psychological symptoms or signs e.g. sad mood, depressed 
affect, anxiety, irritability or anger, anhedonia, loss of interest in environment, or activities, 
decreased libido, social withdrawal, guilt feelings, poor self esteem, self deprecatory 
thoughts, poor concentration, obsessive thoughts, multiple physical complaints, 
hypochondrial fears, feelings of hopelessness, recurrent thoughts of dea.th, or psychotic 
symptoms, should be suspected of being depressed. 32,33,34 
Also, patients who present with neurovegatative symptoms and signs such as sleep 
disturbances, decreased energy, appetite disturbances, diurnal mood variation, psychomotor 
retardation or agitation, should be screened for depression. 32,33,34 
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2.1.3 INSOMNIA 
Insomnia is an experience of inadequate or poor quality sleep characterised by either 
difficulty falling asleep, difficulty in maintaining sleep, waking up too early in the morning 
and sleep that is not refreshing, and compromises daytime functioning.42 
Acute insomnia is a period of sleep difficulty lasting between one night and a few weeks. 
Chronic insomnia refers to sleep difficulty occurring at least three nights per week for one 
month or more.42 
Acute insomnia is often caused by emotional or physical discomfort, such as any significant 
life stressors, acute illness, environmental disturbances (such as noise, light, and 
temperature), and jet lag.42 The disturbance often develops in association with negative 
conditioning to sleep and the sleep environment The patient has increased anxiety as it nears 
sleeping time and often "tries too hard" to fall asleep, further increasing the level of arousal 
and anxiety and thus further decreasing the ability to sleep. Very often if the acute stressor or 
disturbance is removed, patients develop a normal sleeping pattern again. In some patients, 
however, their confidence in the ability to fall asleep, decreases and the patients become 
more apprehensive about their poor sleeping patterns and may develop chronic insomnia, as 
well. 
Chronic insomnia may be caused by many different causes either acting on their own or in 
conjunction with other health problems.42 The hallmark of chronic insomnia is the focused 
absorption of the patient on the sleep problem itself. Patients with major depression 
complain of either difficulty in falling asleep or of early morning aWakening. 
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Patients with bipolar mood disorder, in the manic phase have decreased total sleep, but do 
not experience fatigue when awake. Patients with dysthymia, often report difficulty with 
falling asleep and not feeling fully rested. Patients with anxiety disorders, frequently have 
difficulty initiating sleep, when they lie in their beds and are constantly thinking about their 
anxiety- producing states. Patients with personality disorders, often report insomnia Active 
psychosis of any type also produces disturbed sleep. Caffeine and other stimulant xanthines, 
found in tea, coffee, chocolate or cola drinks, can also cause difficulty with sleep. 31,32,33,34 
Numerous medical conditions can cause insomnia Chronic pain is a well known cause of 
insomnia The many causes for delirium can cause sleep difficulty. Patients with 
cardiopulmonary disease can have symptoms such as orthopnea, paroxysmal nocturnal 
dyspnoea, or nocturnal angina, keeping them awake at night. Patients with sleep apnoea can 
also have disrupted sleep. Prostatism, diabetes, urinary tract infections, causing urinary 
frequency, can also interrupt sleep. Repetitive twitching of the legs, whilst sleeping, (often 
unrecognized by the patient), called nocturnal myoclonus, is another cause of poor quality 
sleep.31,32,33,34 There is also a insomniac state called primary or idiopathic sleep disorder, 
where patients have objectively verified difficulty falling asleep or maintaining sleep in the 
absence of any underlying disorder.31 Some patients may also have a persistent complaint of 
insomnia, without any objective evidence of a cause.31 
2.1.4 PAIN 
Acute pain is typically associated with acute disease or injury. Its main aim is to warn the 
patient of tissue damage. It has a well defined temporal onset and its course is usually to 
subside as healing continues. S3,SS 
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Chronic pain may appear when an acute pain episode does not resolve in the expected time. 
or when pain emerges with no definite precipitating factor. It may persist for months or years 
and serves no biological function.53,55 
Nociceptive pain is pain primarily due to an injury or inflammation of somatic or visceral 
tissue.53 
Nociceptive somatic pain53 is caused by activation of peripheral and central nociceptors. 
superficial and deep tissues. It is wellloca1ised. aching or gnawing in character e.g. joint 
pain, myofascial pain, inflammatory and ischaemic pathology. 
Nociceptive visceral pain is caused by distortion of viscera, distension of hollow organs. 
infiltration, organ compression or capsular stretching. It is poorly localized. and often 
referred to the skin surface, which may be warm and tender. It is squeezing or pressure-like 
in character and may have associated autonomic symptoms e.g. gallstones. kidney stones. 
gastric ulcer. bowel obstructiOn.53 
Neuropathic pain is caused by injury to the central nervous system.53 Pain may be referred 
along the nerve pathway. It may be severe. constant, vice-like with paroxysms ofbuming or 
shock-like sensations e.g. diabetic neuropathy. post herpetic neuralgia, phantom limb pain.53 
2.1.5 SOMATIC PRESENTATION OF A PSYCHIATRIC DISORDER 
Somatoform disorders. conversion and dissociative disorders and factitious disorders and 
malingering are somatic presentations of psychiatric disorders. 34 
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Somatoform disorders are conditions in which physical symptoms are present for which no 
organic or physiological basis can be found and where there are demonstrable underlying 
psychological factors or conflicts Le. the physical symptoms are manifestations of underlying 
psychological distress or disease.33 There are three types ofsomatofonn disorders viz. 
somatofonn pain disorder, somatisation disorders, and hypochondriasis.33 Somatofonn pain 
disorder is characterised by the presence of severe and prolonged pain, which is the primary 
complaint and is not consistent with known neuroanatomic distribution of pain receptors. No 
organic aetiology is detectable to explain the cause ofpain.33 Somatisation disorders are 
poly symptomatic disorders in which the patient experiences multiple unexplained symptoms 
without physical disease and in the context of a disturbed personality.33 Hypochondriasis is 
characterised by an unrealistic preoccupation with the fear of having, or belief that one has, a 
serious disease.33 Such a patient interprets physical signs or symptoms as evidence to support 
his or her views. 
Factitious disorders are characterised by conscious, deliberate and surreptitious feigning of 
physical or psychological symptoms to simulate disease. Patients demonstrate an 
unexplained psychological need to assume the sick role.34 Malingering is characterised by 
intentional production of physical or psychological symptoms. This is motivated by 
identifiable external incentives (e.g. fmancial compensation or evading the police or criminal 
proceedings).34 
Anxiety, depression, insomnia, chronic pain conditions and patients with somatisation, may 
display common symptoms that may be related and conditions may co-exist, as well. It may 
be very difficult to differentiate signs and symptoms among the conditions, since they may 
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occur in all of the above situations. Antidepressants are used to treat patients with these 
conditions, and were appropriately prescribed for the patients in our study. 
3. AIM OF STUDY 
The aim of this study is to describe how doctors are prescribing low dose antidepressants at 
Heideveld Community Health Centre. 
4. OBJECTNES 
1. To detennine how many patients are being prescribed low dose antidepressants at Heideveld 
Community Health Centre. 
2. To see what sort of dosages are being prescribed as low dose, (e.g. IOmg, 2Smg, sOmg, 
7Smg) most frequently. 
3. To see if indications for the use oflow dose antidepressants are being recorded. 
4. To identify the indications for which low dose antidepressants are being prescribed, where 
they had been recorded. 
S. RESEARCH METHODOLOGY 
5.1 STUDY DESIGN 
A retrospective descriptive study was done. 
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5.2 STUDY POPULATION 
All patients attending Heideveld Community Health Clinic, for whom low dose 
antidepressants were being prescribed, by the clinic doctors, during a two week period in 
2000. (The study excluded known psychiatric patients). 
5.3 SAMPLE SIZE CALCULATION 
A pilot study, done at the Heideveld Community Health Clinic, revealed, that 30%, of 
patients attending our community health clinic were currently on low dose antidepressants. 
With the assistance ofa biostatistician from the University of Cape Town, Community 
Health department, the sample size required for the study which would give a 95% 
confidence interval, was calculated to be 500 patients. 
5.4 SAMPLING STRATEGY 
All folders of patients seen by the five medical officers at Heideveld CHC, over a period of 
two weeks, were retrieved and reviewed in the study. 
A sample of 50 patients a day, using the statistics sheets from the doctors, was selected. (The 
usual statistics sheets being used by the community health centre, contains only the folder 
numbers of the patients seen by that particular doctor. Ten patients' folders from each doctor, 
per day, for five days of the week, for a period of two weeks, were drawn by the reception 
staff, and kept for the study. By systematic sampling, folders were selected from the statistic 
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sheets. If a doctor had seen 50 patients for the day, every fifth patient's folder was drawn for 
the study. If the doctor had seen 40 patients for the day, every fourth folder was drawn, and if 
the doctor had seen 30 patients for the day, every third folder was drawn, thus selecting the 
random 10 patients chosen for the study. Folders used were flagged, to avoid using the same 
folder twice, should a patient be seen more than once during the two week study period. 
The patients seen at the clinic are seen in no particular order, since the chronic patients and 
the patients with acute illnesses are all seen together. This ensured a good spread of patients 
seen, including patients seen at all of the clinics, and thus avoiding bias towards one 
particular chronic illness. 
(We have specific days for the chronic care clinics e.g. Diabetic clinic days on Mondays and 
Thursdays, hypertension clinic days on Tuesdays and Fridays, and asthmatic clinics on 
Wednesdays). 
There was no way that one would have known whether the patient, whose folder number we 
had selected, was a chronic clinic patient or a non clinic patient, hence ensuring absence of 
bias towards patients with chronic illnesses, in the sample selection of patients seen. 
Records were reviewed and data was captured on a data capture sheet. 
Demographic data: age and gender was recorded. 
The dose of the antidepressants per patient was recorded. 
The indication for its use was recorded. 
Where the indication of its use was not recorded, this was also documented. 
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5.5 DATA MANAGEMENT 
Data was captured, using Epi-info 6, which is a word processing, database and statistical 
package used in public health. 
6. ANALYSIS 
Statistical analysis was performed using the Epi-info 6 package and data was analysed with 
assistance from UCT Department of Biostatistics and the MRC. Descriptive statistics was 
compiled using frequency tables and graphs. 
Bivariate analysis was carried out, using chi square tests and Fisher's exact tests. 
Numerical data was summarised using either the measures of central tendency or the 
measures of dispersion. The measures of central tendency incorporated the mean, median 
(50th percentile) and mode, while the measures of dispersion incorporated the inter-quartile 
range and the standard deviation. Where the distribution of the data were observed to be 
symmetric, (normally distributed), the data was snmmarised, using the means and standard 
deviation. However, for skewed data, the median and quartiles were used as summary 
statistics, because median and quartiles are not as easily influenced by extreme values and 
skewed distributions, as are means and standard deviations. 
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7.ETInCS 
The protocol for my thesis was approved by the University of Cape Town Ethics Committee. 
My reference number was 19912001. Access to the folders was secured by obtaining 
permission from the Community Health Care Organization's superintendent, Dr Edmund 
Michaels, as well as the Heideveld doctor in charge, Dr Bbanu Daya. 
Permission was sought from colleagues at the Heideveld Community Health Centre to use 
documented information from their consultations, regarding diagnoses and treatment plans. 
Only folder numbers were used to flag folders that were used. Complete anonymity of 
patients was ensured. 
Confidentiality was ensured at all times. 
There were no outside vested interests or monetary gains to be attain~ whilst doing the 
project. 
8. REPORTING OF RESULTS 
The reporting of results was addressed to all doctors whose patients were used in the study, 
as well as all interested parties at the Community Health Centre. Feedback was given to the 
doctor in charge as well as to the medical superintendent of the Community Health Service 
Organisations. 
25 
9. RESULTS: PRESENTATION 
9.1 NUMBER OF PATIENTS ON LOW DOSE TRICYCLIC ANTIDEPRESSANTS 
Of the 500 folders reviewed, 153 (30,6%) of the patients were prescribed low dose tricyclic 
antidepressants at the consultation, during the time that the study took place. 
9.2 DEMOGRAPIDC DATA 
9.2.1 AGE GROUPS 
The patient's ages were categorised in 10 year age intervals. 
The youngest of the patients in the study population was 16 years old and the oldest patient 
was 90 years old. 
1 patient was in the age group category 10-19 (0.65%). 
10 patients were in the age group category 20-29 (6.54%). 
16 patients were in the age group category 30-39 (10.46%). 
27 patients were in the age group category 40-49 (17.65%). 
51 patients were in the age group category 50-59 (33.33%). 
32 patients were in the age group category 60-69 (20.92%). 
12 patients were in the age group category 70-79 (7.84%). 
3 patients were in the age group category 80-89 (1.96%). 
1 patient was in the age group category 90-99 (0.65%). 
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Agegroup 
Dose (mg) Total number 
10 12.5 20 25 50 75 of pationts 
I -J 
~ 1~:..'9 1 0 0 0 0 0 tj 20·29 6 0 0 0 3 1 30·39 6 0 0 8 1 1 16 
40-49 6 0 0 16 2 3 27 
SO-59 24 1 0 18 5 3 51 
, 
60-69 10 0 1 17 2 2 32 
-
70-79 5 0 0 4 3 0 12 
BO-89 1 0 0 0 2 0 3 
, 
90·99 '- 0 0 0 0 0 1 
t'KiIlKE 3 
" 
The median dose of tricyclic used was 25mg. 
The highest frequency of low dose antidepressant use was in the 50-59 year age group 
category. (Figure 3) 
The highest frequency for both sexes for the use of low dose antidepressant was in the 50-59 
year age group category. (Figure 3) 
9.4 REASONS FOR ANTIDEPRESSANT USAGE 
9.4.1 DOCUMENTATION OF REASONS 
44% of the folders had one reason for the use of antidepressants recorded. 
29010 of the folders had two reasons recorded. 
10% of the folders had three reasons recorded. 












9.4.2 REASONS RECORDED 
Of the 83% (153) of the folders that reasons were recorded, 
28% (43) had insomnia 
20% (31) had headaches 
14% (18) had stress 
18% (21) had anxiety 
8.5% (13) had fibromyalgia or complaints of muscular pains 
6.5% (10) had complained of chest pain 
5.9% (9) had osteoarthritis 
5.2% (8) had complained of general body pains 
5.2% (8) had neuropathy 
3.9% (6) had chronic lower backache 
2.6% (4) had depression 
2.6% (4) had been in bereavement 
2.6% (4) had complained of abdominal pain 
2.6% (4) had complained of chronic leg pain 
1.96% (3) had complained of dizziness 
1.96% (3) had complained of chronic pain (related to old fractures) 
1.96% (3) had urinary incontinence 
1.3% (2) had complained of tiredness 
0.65% (I) had been complaining of menopausal symptoms 
0.65% (1) had post herpetic neuralgia 
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0.65% (1) had myelopathy 
0.65% (1) had phantom limb pain 
0.65% (1) had complained of an unexplained "funny" taste in the mouth 
0.65% (1) had peripheral vascular disease 
0.65% (1) had synovitis 
0.65% (1) had complained of palpitations 
Of the above recorded symptoms, 16 (of the above categories) can be included in the chronic 
pain syndromes (i.e. headaches, fibromyalgia, chest pain, general body aches, neuropathy, 
osteoarthritis, chronic lower backache, chronic pain at old fracture sites, post herpetic 
neuralgia, myelopathy, phantom limb pain, "funny" tastes, peripheral vascular disease, 
synovitis, chronic leg pain, abdominal pain). 
5 of the symptoms can be classified as being either ofpsycbiatric or psychological nature 
(Le. insomnia, anxiety, stress, depression, bereavement). 
The other 5 i.e. dizziness, urinary incontinence, tiredness, menopause related symptoms and 
palpitations were classified as "others." 
Where two or three symptoms were recorded, there was an overlap of the above categories. 
There were no indications in the folders as to the possible reasons for the usage of 
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9.4.3 RELATIONSHIPS BETWEEN SYMPTOMS DOCUMENTED 
The relationships between the following chronic pain symptoms and 
psychological/psychiatric symptoms (stress, anxiety, insomnia) were analysed, where there 
were more than six symptoms in the category recorded i.e. headaches, fibromyalgia, chest 
pain, general body aches, neuropathy and osteoarthritis. 
INSOMNIA 
There was a significant association with headaches (p=O.OS). 
There was no significant association with fibromyalgia syndrome (p=O.07). 
There was no association with chest pain. 
There was no association with general body aches. 
There was no association with neuropathy. 
There was no significant association with osteoarthritis (p=O.4S). 
ANXIETY 
There was no significant association with fibromyalgia syndrome (P=1). 
There was no significant association with headaches (p=O.76). 
There was no significant association with chest pain (p=0.31). 
There was no significant association with general body pains (P= 1). 
There was no association with neuropathy. 
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There was no association with osteoarthritis. 
STRESS 
There was no significant association with fibromyalgia syndrome (p=O.21). 
There was no significant association with headaches (p=0.31). 
There was no significant association with chest pain (p=O.63). 
There was no significant association with general body aches (p= 1). 
There was no association with neuropathy. 
There was no association with osteoarthritis. 
Although there was no statistical significance, (besides headaches and insomnia) amongst the 
factors above, the clinical significance is well known, and there is an association with all the 
factors as mentioned in the section titled "Background medical information about main 
factors in study" (See literature review).31, 32, 33, 34 
10. SUMMARY OF FINDINGS 
Basically, our objectives were achieved: 
Objective 1: To determine how many patients were prescribed low dose antidepressants: 
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30,6% of the patients, in our study at Heideveld Community Health Clinic, were prescribed 
low dose antidepressants. 
Objective 2: To see what sort of doses were being prescribed as low dose antidepressants, 
most frequently: 
See Figure 3 
Minimum dose used was IOmg and the maximum dose used was 75mg of tricyclic 
antidepressant. 
Objective 3: To see if indications for the use oflow dose antidepressants are being recorded: 
83% of the folders had reasons recorded. 
17% of the folders had no reason recorded. 
Objective 4: To identify the indications for the use of low dose antidepressants: 
See Figure 5 
Basically, the reasons for the use of low dose antidepressants were for chronic pain 
syndromes, somatic symptoms, insomnia, and for psychological or psychiatric reasons 
(anxiety or depression related symptoms). 
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11. DISCUSSION 
Amitriptyline has often been described as a "wonder" drug by consultants, when we present 
our difficult patients to them. If no known cause of a particular symptom presentation can be 
found, usually after extensive investigations, consultants have advised: "Try some 
Amitriptyline. See if it will help_" In most of the cases, in their experience, this has proved to 
be true, and the antidepressant has helped. Another consultant favouring Amitriptyline, for 
these patients, suggested that Amitriptyline should be added to our drinking water, since he 
was sure it would cure many of the modem ailments, in our primary health care setting. 
For the purposes of our study, we considered a low dose, to be I0-75mg of tricyclic 
antidepressant, as discussed with our consultant psychiatrist in the South African setting. 
Anything higher than 75mg, is considered full antidepressant dose.14 
The first three objectives achieved were peculiar to the Heideveld Community Health Centre 
only. 
It is also noted that the findings of tricyclic antidepressant prescriptions in 30010 of the files 
reviewed in the pilot study closely matched the 30.6% found in the definitive study. 
As found in previous studies 2,4,5, doctors often do not record psychiatric diagnosis when 
prescribing psychotropic medication. My study also lacked a diagnosis in 17% of the folders 
reviewed. It is likely that the reasons for not recording a diagnosis, in my study, would 
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closely resemble Broadhead's4 findings which were "inadequate evaluation by the 
physicians, a lack of proper physician training, a lack of vocabulary for describing 
recognised psychological distress in patients, poor record keeping in general or physician's 
reluctance to record a mental disorder as the diagnosis". 
As can be seen by our findings, there was widespread use of low dose antidepressants for the 
various conditions listed. According to the literature review these conditions are known to 
respond to low dose antidepressants. In our study we assumed that doctors had made the 
correct diagnosis and that they were prescribing low dose antidepressants for the appropriate 
conditions, therefore one could state that the low dose antidepressants were used 
appropriately at our community health centre. 
11.1 THE USE OF TRICYCLIC ANTIDEPRESSANTS IN TREATING ANXIETY 
As can be seen in above symptoms and signs listed for anxiety recorded in our study there 
were symptoms like insomnia, fatigue, weakness, palpitations, chest pain, dry mouth 
(causing possible tlfunny tastetl recorded in our study) and dizziness, all symptoms that could 
have been part of anxiety states. Very often the patient presented with only the one symptom, 
e.g. palpitations, a symptom of the cardiovascular disease. Depending on the medical 
officer's approach and history taking technique, an anxiety state could have been completely 
missed and one could have over-investigated that particular patient, looking for a particular 
medical condition, which could have caused his or her palpitations. This could be extremely 
costly, (ECG's, laboratory testing, referral to a cardiologist, etc) as well as very frustrating for 
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both the patient and the doctor, especially if no conclusion is reached. Taking a full medical 
history, including a psychosocial history, could get the doctor to home in to the actual 
diagnosis quicker, with much more satisfaction for both the patient and the doctor.8o,8s,86 
The actual first presentation to the practitioner could have been the very first opportunity, as 
well as possibly the only opportunity, that the patient had to present their problem to the 
doctor, in some cases. It would have been very unfortunate for the patient, if the patient left 
the rooms without feeling "heard" by the doctor, and also for the doctor, who could have 
missed an opportunity to really get to know his patient, and get the patient to have "opened 
up" to the doctor. Alternatively, the patient feeling "not heard" would go around "doctor 
shopping" again, until he did get some relief from some doctor, who may have been more 
sensitive to the patient's needs or more thorough with the history taking. It is extremely 
important, though that the doctor does not miss an important medical condition that could be 
responsible or otherwise co-exist with the underlying anxiety disorder. Therefore the 
necessary baseline tests have to be performed, to rule out any medical conditions, before 
treating the patient only for the anxiety disorder that he presents with. It is also important to 
classify the type of anxiety disorder that the patient may have presented with. From our 
study, the type of anxiety disorder that the patient presented with was usually not 
documented. The medical officers may well have been of the condition they were dealing 
with, when they treated the patient for an anxiety disorder, but to another doctor who would 
follow up that patient, the patient would probably have to repeat his or her story to the next 
doctor again. In many of our patients, the reasons for their anxiety states had caused great 
discomfort already (e.g. violence, rape, domestic conflict, etc.), and having to repeat the story 
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to another doctor, is a further anxiety- provoking and traumatic experience in the majority of 
cases. The nature of the episode may have been another reason for the doctor's poor record-
keeping or maintaining patient confidentiality, by not recording the exact anxiety diagnosis, 
in our study. The reason for the patient's anxiety state is a very important part of the records, 
which was not very well documented in our records. Was the patient treated for a generalised 
anxiety disorder? Did the patient suffer from a panic disorder? Did the patient have a simple 
or social phobia? Was the patient someone suffering from an obsessive compulsive disorder? 
Could it have been a post traumatic stress disorder, causing the anxiety? Did the patient have 
a possible adjustment disorder with an anxious mood? Could the patients have been abusing 
anxiolytics, alcohol, benzodiazepines, or any other sedating agen4 which could have 
reflected an underlying anxiety disorder? 
Sullivans2 reports that anxiety disorders are found at a rate greater in patients with chronic 
pain, than in the general population. Panic disorders and generalised anxiety disorders were 
reported to be most common. He stated that patients with panic disorder often presented to 
the doctors with chronic migraine, headaches or chest pain, for investigation. 
All these factors causing symptoms in our patients, could have been probable causes for a 
label of "anxiety", resulting in receiving treatment with low dose antidepressants. 
It is important to know these factors and be aware of them when treating patients with their 
anxiety conditions. 
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11.2 THE USE OF TRICYCLIC ANTIDEPRESSANTS IN TREATING DEPRESSION 
In our daily practice at the community health centre, there are so many patients with several 
psychosocial stressors that it is not uncommon for our patients to present with depression, or 
transient depressive states. It is thus important to screen for depression, when a patient presents 
with signs or symptoms of a depressive state. In my experience many of the patients at our 
community health centre, presented with chronic dysthymic disorders, due to their chronic 
exposure to poor life circumstances (poverty, unemployment, financial problems, inadequate 
housing, sanitation, gangster-ridden areas, substance abuse, violence, etc.). 
Dysthymia and major depression can coexist, and must be distinguished from each other, and 
treated adequately. In patients with dysthymia, their symptoms are less severe than in major 
depression and neurovegatative features are fewer.32 This could also be another reason for the 
use of low dose antidepressants prescribed, to assist with symptom management. (In the 
diagnosis of "depression", made by the medical officers in our study, no distinction was made as 
to the type of depression diagnosed. Was the patient just transiently depressed, and symptomatic 
tricyclic antidepressant was prescribed, or was a major depression being treated, just starting off 
with low dose tricyclic antidepressant? The answer was not obvious from the notes recorded). 
Yet again, co-morbid disorders frequently exist, and must be recognised. Van Balkom et al47in 
their study, stated that about one third of an elderly population with phobic disorders and 
generalised anxiety disorder also had major depression. He also found that patients with co-
morbid anxiety and depression had more severe psychiatric complaints. Roberts et al69 reported 
that in previous research, it was shown that women, the less educated, the unmarried, those with 
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health and disability problems, those with more negative life events, those with less social 
support, and greater isolation" were found to be more at risk for depression. Our study had a 
preponderance of females. The other factors are common to patients attending the hospital. 
Could this have been a factor causing depression in our patients? Sullivan52 reported that major 
depression is the most important and prevalent psychiatric diagnosis found in association with 
chronic pain. He reports that prevalence ofmajor depression in the general population is 3-5% 
but prevalence in a chronic pain clinic setting, is approximately 30010. He also reported that 
these depression episodes tend to be recurrent In the chronic pain sufferers, in our study, it is 
not known how many patients were really depressed as well. Arnold et al 54 in their study, 
reviewed studies that examined lifetime prevalence rates of psychiatric disorders in patients 
with fibromyalgia and found elevated rates of major depression amongst them. Also, studies of 
family history of psychiatric illness in patients with fibromyalgia, reported elevated rates of 
depression in first degree relatives. They stated that fibromyalgia had an estimated lifetime 
prevalence of approximately 2% in community studies, and that it was at least twice as common 
as rheumatoid arthritis and is also a major public health concern. "Fibromyalgia, general body 
pains, muscular aches" are common symptoms reported in our records. Whether they were 
associated with depression is not known in our study. Van Hook68 reported a lack of time, 
stigma about depression and perceptions that the primary care providers were not interested in 
their concerns, were amongst some of the barriers to the open discussion of depression in 
primary care. In their study, 32% of patients did not want information about their depression 
recorded in their folders. It is possible that patients had requested that their information also not 
be recorded, in our study patients, leading to presumed poor record keeping notes for other 
viewers of records. The severity of the depression, where noted, was also not obvious from the 
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notes, in our study. Very often neither the features of depression were recorded nor how the 
diagnosis was obtained in our study. Did the patient volunteer the symptoms or was it a gut 
feeling by the doctor, once the patient had presented his case? Did the doctor screen properly for 
depression? Why did the doctor use the low dose antidepressant in these cases? The answers 
were not clear from the records. 
11.3 THE USE OR TRICYCLIC ANTIDEPRESSANTS IN TREATING INSOMNIA 
From the literature review we gathered that up to a third of patients seen in the primary health 
care setting experienced occasional difficulties in sleeping, and up to 10 percent had chronic 
sleep problems. It was also noted that the prevalence of insomnia increased in age and was more 
common in females, the elderly, those with chronic illnesses and those with anxiety and 
depressive disorders. 
The causes for insomnia in our study were not clear from our record keeping at Heideveld 
Community Health Centre. (This was not an aim of our study, thus reasons for insomnia were 
not sought, but it poses an important question for future study). From patients seen at our health 
centre, the causes may be numerous. 
Psychiatric causes are believed to be the underlying disorder in more than half of all patients 
complaining of insomnia. 32 Proper history-taking and screening for psychiatric diseases can 
give the reasons for many causes of insomnia Simon et al41 in their study showed that there was 
a considerable overlap between depression and insomnia They stated that depression was a 
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"powerful predictor of disability and health care utilization" but that insomnia appeared to make 
an "independent contribution". Walsh40 also stated that insomnia is a risk factor for new onset 
depression when it persisted for one year. In my experience, patients with psychiatric causes of 
insomnia, patients with personality disorders and patients with chronic medical conditions 
causing insomnia, are all seen on a daily basis at our community health centre, and it is 
important to screen for these diseases when the patients present with insomnia as a symptom. 
Patients with substance or alcohol abuse often also report sleep problems. Sedatives or alcohol 
induce sedation, but causes shallow, fragmented and non- restorative sleep, if used on a regular, 
long term basis.32 Sedatives and alcohol depress respiratory function which can also cause poor 
quality sleep.32 Tolerance can occur with certain sedatives, prompting increased dosages and 
reuse of the drugs, causing a vicious cycle.32Substance abuse is very common in our setting. 
Alcohol abuse is rife on the Cape Flats. Alcohol abuse is the cause of many patients' distress 
when presenting with psychiatric, or psychologic, or even medical, conditions. It is a factor that 
crops up in the majority of cases and plays an important role in the patient's underlying anxiety 
or depression, or conflict state at our community health centre. Stimulant drugs, such as 
amphetamines, activating antidepressants, or that contained in decongestants or slimming 
agents, can also cause insomnia. 32 "Tik", an amphetamine derivative, is currently being abused 
by many children on the Cape Flats. Some use it for its stimulant effects, and some (mainly 
females) are abusing it for its slimming properties. Insomnia is an important symptom of 
substance abuse and should be explored in the history. We see all categories of these causes of 
insomnia in the patients at our health centre but, in our study, the underlying reasons for the 
patient's insomniac states were not documented. Where there were two or more symptoms 
documented e.g. chronic pain and depression, both could have been the cause for the patient's 
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insomnia The use of tricyclic antidepressants would be acceptable in all three conditions, 
except that higher doses are used in the patients that were also depressed Mertz and Fess43 
report that patients with fibromyalgia and chronic fatigue syndrome and a large proportion of 
patients with functional bowel disease complain of "frequent nocturnal awakenings and non-
regenerative sleep. n Interestingly enough, they report that sleep disturbance is more common in 
patients with functional dyspepsia, than with irritable bowel syndrome. It is not known what the 
patient's diagnosis was in the category of "abdominal pain, " in our study. Could the 
antidepressants have been prescribed for chronic pain or was it prescribed for sleep disturbances 
possibly related to it? It is not known, in our study, whether the patients had volunteered 
insomnia as a symptom, or if it was elicited by the doctor in the history taking. The World 
Health Organization Psychological problems in General Health Care survey stated that 
insomnia amongst primary care patients was associated with significant increases in functional 
impairment and days of disability due to illness.41 The National Heart, lung, and blood institute 
working group on insomnia, in their study42 reported that psychiatric disorders account for less 
than 50% of causes of insomnia. Problems encountered during the day such as chronic pain, 
immobility, difficulty breathing, dementia, hormonal changes associated with pregnancy, 
perimenopause and menopause may also cause insomnia They also found that more than half 
of patients, who believed they suffered from chronic insomnia had never discussed the problem 
with a doctor. They reported that insomnia is seldom the main reason for an office visit They 
suggested direct inquiry into a sleep history, in the routine review of systems, in history taking, 
to enhance detecting patients with insomnia.. They report that sleep disturbance is a "reliable 
indicator of psychological ill health, physical ill health or both." Therefore in patients who 
report sleep disturbances, this signals the need for further investigation. This is important in our 
47 
setting, since due to possible time constraints, the patient may not have the time to volunteer 
insomnia as a complaint during the consultation and an important signal like insomnia, could be 
missed. Shapiro22 reports that "teaching about sleep and sleep disorders, in most medical 
schools is inadequate" and that "most doctors have the same unsubstantiated belief about sleep 
problems as their patients e.g. many think that all sleep problems are secondary to illness, 
psychological distress or psychiatric disorder." A study they reviewed showed that the average 
doctor asks less than three questions about insomnia before planning treatment, whereas there 
are many important questions that should be asked about onset of sleep, length of sleep and the 
patient's daytime perfonnance. (Due to inadequacy of record keeping, it was not possible to 
report on questions asked and doctor's approach to insomnia, in our study, even if this is an aim 
for future study). 
11.4 THE USE OF TRICYCLIC ANTIDEPRESSANTS IN TREATING CHRONIC PAIN 
In our study, terms such as "general body pains" chronic "abdominal pain", or "chest pain" were 
very non-specific. It is not clear if these were genuine physical symptoms (still unexplained, 
still to be investigated; or vague presentations of an underlying medical disorder), or if they 
were part of somatic presentations of a psychiatric disorder. On the other hand, phantom limb 
pain, post herpetic neuralgia, fibromyalgia are examples of definite chronic pain entities, which 
are responsive to tricyclic antidepressants. As in Broadhead's study4, the diagnosis clusters 
within the tricyclic responsive categories, were low back pain diseases and syndromes, peptic 
disease, fibrositis, myalgia, arthralgia, headaches, peripheral neuropathy, rheumatoid disease, 
and irritable bowel disease. He stated that most of these diagnoses are not purely non-
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psychiatric and may often be accompanied by an Axis 1 diagnosis such as a "psychological 
factor affecting a physical condition". This could very well be the case in some of our 
diagnoses, as well. Many of our patients often have many psychological factors together with 
their medical illnesses. Bill 0' Neill82 reports that for most patients, physical pain is only one of 
several symptoms they present with. Pain relief should be seen as "part of a comprehensive 
pattern of care encompassing the physical, psychological, social and spiritual aspects of 
suffering." Physical aspects of pain cannot be treated in isolation from other aspects, nor can 
patients' anxieties be effectively addressed when patients are suffering physically. The need for 
a multidisciplinary team approach is necessary to alleviate this suffering. It is not known, in 
some of the cases, whether other health care officials such as the social worker, physiotherapist, 
or psychiatrist were consulted in our study. This could have happened but the referral of the 
patient to the health official was not documented in our records. Reis et al59 reported that 5-10% 
of individuals with acute episodes oflower backache develop a chronic condition. Lower back 
pain is the single most common cause of limitation of activity in patients younger than 45 years, 
according to them. Patients are often not satisfied with the care they receive for lower back pain 
and clinicians fmd it one of the most difficult and unrewarding aspects of clinical medicine. 59 
Their study documented that chronic lower back pain is a "biopsychosocial condition in which 
psychosocial and patient-centred variables playa role in predicting the clinical course". In their 
study of chronic pain sufferers, they identified 7% of patients with depression, 37% with a 
family history of chronic pain, 36% lacked family support during the pain episode, and 8% of 
family members and 9010 of work colleagues expressed their doubts about the severity of their 
symptoms. They suggested that the patient-doctor agreement on sick leave days, overall 
satisfaction with their first office visit for the episode, patients coping style and delegitimisation 
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of chronic lower back pain by the family, are factors that emphasised the biopsychosocial and 
patient centred models of care, which should be implemented by primary care doctors. 
Schmader60 stated that the outcome of chronic pain included fatigue, sleep disturbance, 
anorexi~ depression, social withdrawal, impaired activities of daily living and profound 
lowering of quality oflife. These factors are commonly seen in our setting, and yet again the 
factors such as disturbed sleep, depression fatigue and chronic pain were factors common in our 
study. Anderson74 reports that patients suffering from their chronic pain resulted in exhibition of 
pain behaviours such as abnonnal physical positioning, talking about their pain, multiple doctor 
visits, unemployment, excessive bed rest, limping, wincing, or crying. They may be faced with 
many other stressors besides the physical ones such as vocational, financial, or marital stressors. 
These stressors are quite common in our Heideveld community centre, and it is not unusual for 
the patients to present with all three and more stressors added to their physical ailments. He 
suggested that the easiest thing for the patient suffering from chronic pain, is to "retreat into a 
world of illness that is acceptable to all", for it is the "sick person who bas respectable 
disability" and not the "person who cannot cope with his daily living." He suggested that the 
doctors having difficulty treating patients with chronic pain, view the patients' environment and 
psychosocial causes of chronic pain as "real," then they would be able to understand their pain 
as being "real" in the absence of a definitive diagnosis. Sullivan52 reported that substance abuse 
may arise in conjunction with the chronic pain problems, or it may precede it. He stated that 
substance abuse impedes rehabilitation and needs to be addressed aggressively. Substance abuse 
is quite common in patients attending our clinic, but it was not ascertained, in our study, if it 
was indeed a factor in our chronic pain sufferers. In the study done by Hoss19 they were also 
uncertain if their patients with chronic pain had pain secondary to underlying psychiatric 
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conditions such as anxiety, dysthymi~ somatisation or whether these psychiatric problems were 
unrelated or caused by their chronic pain. Diane Hoss 19 states that a psychiatric cause or overlay 
has been reported in patients with chronic pain syndrome and that many of the chronic pain 
syndromes were initially thought to represent a psychiatric disorder only, but she stresses that 
one should exercise caution when reviewing data describing a personality profile or a 
psychiatric disorder, and not be clouded by it, in treating patients with this condition. LeiandS3 
in their study of older patients stated that symptoms of chronic pain, anxiety and depression are 
often associated and may intensify each other. This could be a reason for the overlap of 
symptoms reported in our data as well. 
Feinmann61 states that there is still some dispute as to whether the tricyclics exert their effects 
via analgesic or antidepressant pathways. She states that the complex association between pain 
and depression has created some confusion and that pain has been classified as a symptom of 
"masked or atypical depression" or even a "depressive equivalent." 
StaufferS reviewed the neurophysiologic similarities between chronic pain and depression. 
Both of these are accompanied by sleep disturbances and manifests with somatic symptoms, 
making the distinctions difficult Our medical officers may be aware of these similarities, and 
thus be treating all of these with initially low dose tricyclics, possibly planning to review and 
increase doses of antidepressants used on follow up visits. 
Richeim~ concluded that tricyclic antidepressants were commonly used in low to intermediate 
doses, even in situations where there were "neither side effects nor optimal clinical response in 
his chronic pain clinic patients. From reviewing studies done, they formed a clinical impression 
that tricyclic antidepressants doses are rarely maximised in treating chronic pain disorders. 
Godftey6 stated that it was important to remember that there is a one to three week delay in 
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achieving the maximum sleep modification at any given dose, therefore increasing or decreasing 
dosages should not be done too rapidly. 
EgbunikeS8 stated that it is important to differentiate the indication for treatment, since the 
dosage range for analgesia may be much lower than that needed for the antidepressant effect. 
He also reported that the patients with depression may report more profound side effects 
associated with tricyclics. Our medical officers may have been exercising caution in certain 
cases, where low dose tricyclics were prescribed, in our study. 
Interestingly enough, in Broadhead's study4 he also found that primary care doctors paralleled 
specialist's prescribing habits for prescribing tricyclic antidepressants for certain conditions (e.g. 
those of neurologists for low back pain, fibrositis, headache and peripheral neuropathy, or those 
of gastroenterologists for irritable bowel disease). The specialist's patients were more likely to 
have received antidepressants, since their patients are selected and referred and may already 
have failed other treatments, prior to their having received the antidepressants. The doses of 
antidepressants used, were not recorded in their study. It would have been interesting to have 
found the dosages used by specialists for their patients, to see if they also used low doses or 
higher doses of antidepressants. 
Erskine et alS7 in the opening statement of his article, said that "chronic pain is undoubtedly the 
worst taught, least understood and most neglected subject in modern medicine", despite the fact 
that "pain relief is one of the most therapeutic goals of the medical doctor." 
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11.5 THE USE OF TRICYCLIC ANTIDEPRESSANTS IN TREATING SOMA TOFORM 
DISORDERS 
Patients at our community health centre, often present with numerous somatic complaints. 
Many of these can be part of a true medical or psychiatric disorder as well. An organic or 
physiological disorder must be excluded, before labelling a patient as having a somatoform 
disorder. There are clear guidelines established for this disorder. 
From the literature review, studies had shown that somatoform disorders produce significant 
impairment in patients functioning and quality of life and are associated with increased health 
care cost and services. Somatoform disorders were found to be common in females in the 
elderly, in patients with poor social support and also in patients with chronic physical disorders. 
This situation is well recognised in our hospital setting. Our study had a female predominance. 
(Our hospital notably sees more female patients, elderly patients and patients with poor social 
circumstances on a daily basis as well. Reasons for this were not evaluated in our study). 
Medical illnesses causing somatisation and depression are also more common in older people 
therefore a clear understanding of the prevalence and association of somatisation among older 
people is needed. It can be time intensive when gathering sufficient information from the patient 
and medical records to ascertain that a physical explanation for somatic complaints in these 
patients is unlikely, when establishing the presence or absence of a somatoform disorder. In our 
setting, time is often limited due to vast numbers that the clinic sees and shortage of statI. 
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Diagnostic efficiency is a major issue at our clinic, but according to Kroenke71, it is a major 
issue in general primary care as well. Interestingly enough, he states that the primary care 
doctor's gut feeling about a symptom being medically unexpla.ined, is quite good and that few 
patients with symptoms initially judged to be somatoform were later found to have occult 
serious diseases at follow up visits. Leserman et al70 in his study, states that many different 
types of stressors contributed to poor health outcome. These included "traumas and losses, such 
as sexual and physical abuse, death or illness in a close family member, turmoil in one's 
childhood home and recent negative stressful events. II Jo Roberts69 reported that somatisation 
and medical problems were common in victims of childhood sexual abuse. Common problems 
included insomnia, gastrointestinal problems, obesity, chronic pain, headaches and 
somatisation. In a study reviewed by her, she reported that 84% of survivors of abuse were 
never asked about the abuse. The researcher concluded, in her article that most survivors wanted 
to be asked about previous abuse, about problems encountered during examination and to have 
their discomfort noted and attended to. Bridges and Goldberg et al66 also stated that a "disturbed 
early family environment characterised by an unstable upbringing, psychosocial problems in 
siblings, a poor relationship between parents and a lack of maternal affection or oversolicitious 
maternal behaviour," could also result in patients presenting with somatisation in primary care. 
Patients suffering any of these could present to the primary health centre frequently with 
numerous somatic complaints, in their quest for help. Direct query into psychosocial 
circumstances is important to elicit reasons for patients' presentation, when they present with 
unexplained somatic symptoms. These traumatic and unpleasant circumstances, get presented to 
us on a daily basis, and are common encounters to the majority of our patients. Bridges and 
Goldberg et al66 also stated that somatisation has many disadvantages including the risk of it 
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becoming chronic and difficult to treat, and therefore these findings should not "distract 
attention away from the importance of family doctors improving their detection of somatisation 
disorders and learning how to manage them more effectively". 1bis could be quite common in 
our patients as well, although this was not assessed in our study. McDanief2 stated that every 
physical symptom has "some biologic, some psychologic, and often some social component to 
it." Therefore, a doctor needs to be able to address each of these in a balanced and integrated 
way without fixating inappropriately on anyone component of the symptom and therefore they 
also advocate a "biopsychosocial approach that would break: the vicious circle that doctors and 
patients can be drawn into and leads to successful management" 
Included in the somatising patients who presents with somatic complaints that are among the 
most frustrating encounters that present to primary care, are anxious or depressed patients (or 
both), hypochondriacs, chronic pain patients and malingers. They have to be carefully evaluated 
and managed appropriately. 
Low dose Imipramine is one of the drugs used to treat nocturnal enuresis84• From discussions 
with colleagues at the community health centre, our medical officers frequently prescribe it for 
nocturnal enuresis, when the need arises. However, it was interesting to note that nocturnal 
enuresis was not one of the conditions recorded when prescribing low dose antidepressants in 
my study. 
It is interesting to note that in the infonnation package inserts,87,88 that the use of Amitriptyline 
and Imipramine is indicated only for "endogenous depression, mild tranquilising and sedative 
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properties help:ful in alleviating anxiety or agitation that often accompanies depression, 
Parkinsonism, chronic alcoholism and behavioural disorders in children." Should the 
manufacturers not be including the many other non-psychiatric conditions that respond to low 
dose antidepressants amongst the indications for antidepressants in the information package 
inserts as well? 
12. LIMITATIONS OF THE STUDY 
I chose to do a retrospective study, for my project Howie83 states that "retrospective research 
analyses material which is already available and has not been collected with the aims of the 
specific project in mind." It can easily survey very large quantities of information and can cover 
greater periods of time than in prospective studies. He reports that information is, however, 
rarely of "definable or standard quality and its accuracy may thus be very difficult to judge." He 
also states that information obtained is often capable of showing associations between factors 
studied, but cannot comment on the nature of such associations. I found this to be the case with 
my study. 
I had reviewed 500 folders (a fairly large sample size) over a two week period and managed to 
retrieve the information sought. As HowieS) stated, in terms of accuracy, a major assumption 
was made that the prescribing doctors had indeed made the correct diagnosis in my study. 
The main limitation of the study was the perceived poor or inadequate record-keeping, by the 
medical officers, whose notes in the folders were used for the purposes of the study. Quite a 
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large proportion (17%) of the patients had no diagnosis record~ thus some of the reasons for 
the use of low dose antidepressants are not known. 
There was an overlap of symptoms as the indications for the use oflow dose antidepressants, 
and it is not clear from the notes alone, for which of the symptoms the low dose antidepressant 
was prescribed e.g. chronic pain and insomnia. Both respond to low dose antidepressants, but 
the actual reason for it being prescribed by the doctor is not known. Where for examples, 
depression and insomnia had co-exi~ it is not clear why the doctor then prescribed low dose 
antidepressants, which is inappropriate for depression. 
I was unable to ascertain whether follow-up visits were scheduled to monitor side effects, or for 
steady increases in dose. The latter would be unlikely since usually a monthts supply of the dose 
of the antidepressants was boarded on the medication script. (I did not actually document the 
duration of the prescription, for the purposes of the study, although, it would have been useful, 
for following up the possible treatment of depression in some of the patients). 
Compliance with medication and patient satisfaction with medication was not known either. Did 
the use of low dose antidepressant medication benefit our own Heideveld Community Health 
Centre population of patients with their multiple intrinsic and extrinsic sources of problems, 
which could be unique only to our area of patients, and not likened to studies overseas? This 
question needs to be addressed in subsequent studies in the same cohort of patients. 
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13. THE NEED FOR FUTURE RESEARCH 
From our literature search, we can be satisfied that the use of low dose antidepressants was 
appropriate for use in patients with chronic pain symptoms. It is not known whether our own 
patients were compliant with the medication and whether their symptoms were actually relieved 
with their use. This needs to be explored further. 
Likewise, insomnia is successfully treated with low dose antidepressants, but it is not known 
why so many of our patients needed antidepressants. It is also not known whether they were 
compliant with the medication, and whether they also needed low dose antidepressants for 
underlying depression, anxiety or chronic pain symptoms. 
Was depression under·treated at our facility? This is another question that I identified. 
Depression needs to be adequately treated with proper, higher doses of antidepressants. 
However, in our setting, many of our patients suffer from symptoms that could cause anxiety or 
temporary depression or reactive depression that warrants the use of antidepressants. With their 
follow up visits, their symptoms could have resolved, depending on their situational state. Were 
they truly depressed at the time of their visits? What were their presenting complaints to the 
doctor at their visit? Did the doctor screen for depression? Did the doctor delve into their 
reasons for their insomnia or chronic pain? Did the patient come back for the follow up visits? 
Were dosages appropriatelY increased in patients that were truly depressed, if it was confinned 
at follow up visits? Were patients with depression treated by the medical officers or were they 
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referred to the psychiatrists? How many of the 30,6 % of our patients that were prescribed low 
dose antidepressants were actually missed depression cases? 
Of the patients that did not have a diagnosis recorded, it is not known why they were using low 
dose antidepressants. It would have been a valuable exercise to find out from either the doctor 
or the patient, why the low dose antidepressant was prescribed. 
It would be interesting to find out from the doctors the reasons for their poor record keeping? 
Why was a diagnosis not recorded for 17% of the patients receiving low dose antidepressants? 
Was it a genuine error of omission, in not recording the diagnosis? Or was it similar to studies 
done elsewhere, as gathered in our literature search. Was depression being under diagnosed or 
under treated for any other reason? Were doctors "scared" of using full dose antidepressants for 
fear of side effects or any other reason? Did doctors screen for depression in patients who 
presented with physical symptoms, chronic pain or insomnia? Were doctors happy with their 
consultations? Were they referring appropriately to other health workers where needed to assist 
them with patient care? Did they feel that they were using low dose antidepressants 
appropriately? Did they feel that they were prescribing the antidepressant instead of dealing 
with the patients' possible underlying stressors, e.g. chronic pain, instead of depression, 
insomnia instead of the chronic pain or domestic stressors, which could cause depression in the 
patient? 
It would be interesting to find out from the patients what they thought the antidepressant was 
used for, if their symptoms were relieved by the use of it, whether they were compliant with it, 
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side effects experienced with the low dose antidepressants, and whether they needed higher 
doses on follow up visits. Did the patients think that they were depressed at the time of the 
visit? Did they feel the doctor missed a possible depression at their visit? Were they satisfied 
with the consultation? Were they adequately counselled or referred for counselling where they 
needed it? Did they feel that the low dose antidepressant was prescribed (like the 
physiotherapist in the beginning of the study suggested), to solve their problem, instead of 
counselling them because of time restrictions? In cases where this was indeed the case as well 
(perhaps in the cases where no diagnoses were recorded), was adequate referral made to the 
appropriate authorities e.g. social worker, home carers, etc., to assist them with their problems? 
All these questions arose which were not part of the aims for this study, (thus remain 
unanswered), but could provide valuable material to us for future studies. 
14. RECOMMENDATIONS 
1. Doctors must practice good note taking. Diagnosis must be recorded in folders. It is not only 
essential for study purposes but also for follow up, especially in areas such as the community 
health centres, where continuity of care cannot be assured, because of the high turnover of 
patients. Discussing adequate and appropriate record keeping should be included in both the 
undergraduate and postgraduate teachings in Family medicine. Regular audits on record keeping 
should be carried out, in order to ensure compliance with good record keeping. 
During my study, it was quite difficult to retrieve infonnation from our folders because of poor 
record keeping, and impossible in 17% of study subjects to ascertain a diagnosis. 
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2. Targeting patients with insomnia is the next important recommendation I would suggest. 
Insomnia was the main indication for the patients using low dose antidepressants. Finding out 
why there are so many patients who suffer from insomnia at our clinic, would be an interesting 
and meaningful study. An attempt should be made to identify the underlying reasons for 
insomnia, in our area, and the surrounding neighbouring areas, served by our clinic. (None of 
the folders had any idea of the type of insomnia experienced by patients, nor was there any 
mention of a good sleep history being taken). Doing a study to see how insomnia in general is 
being treated at our community health centre, would also be a valuable exercise. Finding out 
about what the patients have been told regarding insomnia and also if the patients who suffer 
from insomnia have been given appropriate sleep hygiene instructions would be important. 
Ascertain whether antidepressants are just being dished out to patients with insomnia as a 
complaint, or are appropriate attempts being made to correct underlying stressors, underlying 
medical conditions, etc. 
3. Screening for_depression is one of the main recommendations emanating from this study. As 
could be seen from our findings, there is a real possibility that depression could have been 
missed in patients presenting with any of the complaints, all valid, and appropriately treated 
with antidepressants, but higher doses of antidepressants would then be necessary. Ensure 
adequate follow up for these patients and ensure appropriate referral for assistance from other 
members of the health team e.g. social worker, psychiatrist, health care workers, etc. 
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4. Doctors should check to see that chronic pain is being adequately managed. Finding out 
whether patients have adequate pain relief and whether they are compliant with their treatment, 
would be a valuable exercise in our patients. Confirming whether doses being used are adequate 
to give reasonable pain relief could be a part of the study. Ensuring that a multidisciplinary team 
approach towards their care is set in place, and that there is easy access to all partners involved. 
Assisting carers by briefing them about the chronicity of the condition, its treatment, etc. and 
ensuring that there is care for the carers available would be another recommendation. 
5. Target 51-59 year old patients at our day hospital. Finding out what is happening to this age 
group, and identifying the reason behind the need for an increased prescription rate in 
prescribing low dose antidepressants, in this age group, as can be seen in Figure 3. 
Determining whether there is some underlying problem in the ~ whether it be physical, 
environmental, domestic, or financial problems, etc., that may give rise to either an increase in 
anxiety, depression, insomnia, and increased chronic pain in patients with such aftlictions that 
would warrant low dose antidepressant medication, as an aid, and ensuring that patients' health 
needs are being met adequately by our clinic. 
15. CONCLUSION 
In our study we showed that low dose tricyclic antidepressants were appropriately used for the 
conditions known to respond to it, i.e. non-psychiatric indications, as well as for its psychiatric 
indications, in our patients at Heideveld Community Health Centre. 
The study highlighted areas that could form the basis for future research. Hopefully, medical 
officers would practice better record keeping and thus also improve communication, and 
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continuity of care. By paying attention to points of interest that followed from this study ~ 
medical officers could also improve on overall care of patients attending Heideveld Community 
Health Centre with psychiatric conditions, insomnia, chronic pain and somatoform disorders. 
16. ARTICLE OF INTEREST 
A recent article in the Cape Argus Monday August 9 2004~ caught my attention. The headlines 
read that Prozac, an antidepressant, was found in Britain's water. The article mentioned that 
Prozac was used in such large quantities, that it could be found travelling through the sewerage 
network and ended up being recycled back into the water system. The same article reported that 
since 1991 there has been a 166% increase in prescriptions for antidepressants in England (up to 
24 million a year). Another recent study~ reported in the article mentioned that four out of five 
general practitioners admitted to over-prescribing antidepressants. The reasons for this were not 
mentioned. (Our study could share a common topic of interest, recording reasons for use of 
antidepressants, in other areas of the world as well). 
I wonder what the consultant (in our introduction) who suggested putting Amitriptyline in our 
drinking water would have said in response to this article! 
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